Serum Concentrations of 1,25-Dihydroxyvitamin D2 and 1,25-Dihydroxyvitamin D3 in Response to Vitamin D2 and Vitamin D3 Supplementation

被引:90
作者
Biancuzzo, Rachael M. [1 ]
Clarke, Nigel [2 ]
Reitz, Richard E. [2 ]
Travison, Thomas G. [1 ]
Holick, Michael F. [1 ]
机构
[1] Boston Univ, Med Ctr, Sect Endocrinol Nutr & Diabet, Dept Med,Vitamin Skin & Bone Res Lab D, Boston, MA 02118 USA
[2] Quest Diagnost Nichols Inst, San Juan Capistrano, CA 92675 USA
基金
美国国家卫生研究院;
关键词
25-HYDROXYVITAMIN D; HEALTH; RISK; SUNLIGHT; CANCER; ASSOCIATION; PREVENTION; ABSORPTION; NUTRITION; RECEPTOR;
D O I
10.1210/jc.2012-2114
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The purpose of this study was to determine 1,25-dihydroxyvitamin D-3 [1,25(OH)(2)D-3] and 1,25-dihydroxyvitamin D-2 [1,25(OH)(2)D-2] levels in healthy adults consuming 1000 IU vitamin D-2 or vitamin D-3 per day for 11 weeks. Subjects and Design: Blood from 34 healthy male and female adults, aged 18 to 79 years, from a placebo-controlled, double-blind study who received a placebo, 1000 IU vitamin D-3, or 1000 IU vitamin D-2 daily for 11 weeks at end of winter was analyzed. Serum levels of 25-hydroxyvitamin D-2, 25-hydroxyvitamin D-3, 1,25(OH)(2)D-2, and 1,25(OH)(2)D-3 were determined by liquid chromatography tandem mass spectroscopy. Results: Of the adults, 82% were vitamin D insufficient (serum 25-hydroxyvitamin D [25(OH)D < 30 ng/mL]) at the start of the study. Administration of vitamin D-2 and vitamin D-3 induced similar increases in total 25(OH)D as well as in 25-hydroxyvitamin D-2 and 25-hydroxyvitamin D-3, respectively. Compared with placebo and adjusting for baseline levels, 1000 IU daily of vitamin D-2 was associated with a mean increase of 7.4 pg/mL (95% confidence interval, 4.4 - 10.3) in 1,25(OH)(2)D-2, which was accompanied by a mean decrease of 9.9 pg/mL (-15.8 to -4.0) in 1,25(OH)(2)D-3. No such differences accompanied administration of 1000 IU daily of vitamin D-3. Conclusion: Vitamin D-2 and vitamin D-3 were effective in raising and maintaining total serum concentrations of 25(OH)D. Ingestion of vitamin D-2 also resulted in an increase in serum concentrations of 1,25(OH)(2)D-2. This increase was accompanied by a comparable decrease in serum concentrations of 1,25(OH)(2)D-3; therefore, the total 1,25-dihydroxyvitamin D [1,25(OH)(2)D] concentrations did not significantly change after 11 weeks compared with baseline levels. Ingestion of vitamin D-3 did not alter serum concentrations of 1,25(OH)(2)D-3 or total 1,25(OH)(2)D. Therefore, ingestion of 1000 IU vitamin D-2 or vitamin D-3 for 11 weeks was effective in raising total serum concentrations of 25(OH)D as well as sustaining serum concentrations of total 1,25(OH)(2)D. (J Clin Endocrinol Metab 98: 973-979, 2013)
引用
收藏
页码:973 / 979
页数:7
相关论文
共 35 条
[1]   Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland) [J].
Ahonen, MH ;
Tenkanen, L ;
Teppo, L ;
Hakama, M ;
Tuohimaa, P .
CANCER CAUSES & CONTROL, 2000, 11 (09) :847-852
[2]   Vitamin D2 is much less effective than vitamin D3 in humans [J].
Armas, LAG ;
Hollis, BW ;
Heaney, RP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (11) :5387-5391
[3]   Fortification of orange juice with vitamin D2 or vitamin D3 is as effective as an oral supplement in maintaining vitamin D status in adults [J].
Biancuzzo, Rachael M. ;
Young, Azzie ;
Bibuld, Douglass ;
Cai, Mona H. ;
Winter, Michael R. ;
Klein, Ellen K. ;
Ameri, Allen ;
Reitz, Richard ;
Salameh, Wael ;
Chen, Tai C. ;
Holick, Michael F. .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2010, 91 (06) :1621-1626
[4]   Positive association between serum 25-hydroxyvitamin D level and bone density in osteoarthritis [J].
Bischoff-Ferrari, HA ;
Zhang, YQ ;
Kiel, DP ;
Felson, DT .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2005, 53 (06) :821-826
[5]   Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes [J].
Bischoff-Ferrari, Heike A. ;
Giovannucci, Edward ;
Willett, Walter C. ;
Dietrich, Thomas ;
Dawson-Hughes, Bess .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2006, 84 (01) :18-28
[6]   Adiposity, Cardiometabolic Risk, and Vitamin D Status: The Framingham Heart Study [J].
Cheng, Susan ;
Massaro, Joseph M. ;
Fox, Caroline S. ;
Larson, Martin G. ;
Keyes, Michelle J. ;
McCabe, Elizabeth L. ;
Robins, Sander J. ;
O'Donnell, Christopher J. ;
Hoffmann, Udo ;
Jacques, Paul F. ;
Booth, Sarah L. ;
Vasan, Ramachandran S. ;
Wolf, Myles ;
Wang, Thomas J. .
DIABETES, 2010, 59 (01) :242-248
[7]   SERUM VITAMIN-D2 AND VITAMIN-D3 METABOLITE CONCENTRATIONS AND ABSORPTION OF VITAMIN-D2 IN ELDERLY SUBJECTS [J].
CLEMENS, TL ;
ZHOU, XY ;
MYLES, M ;
ENDRES, D ;
LINDSAY, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (03) :656-660
[8]   Distribution of the Vitamin D receptor and 1α-hydroxylase in human brain [J].
Eyles, DW ;
Smith, S ;
Kinobe, R ;
Hewison, M ;
McGrath, JJ .
JOURNAL OF CHEMICAL NEUROANATOMY, 2005, 29 (01) :21-30
[9]   Plasma 25-hydroxyvitamin D levels and risk of incident hypertension [J].
Forman, John P. ;
Giovannucci, Edward ;
Holmes, Michelle D. ;
Bischoff-Ferrari, Heike A. ;
Tworoger, Shelley S. ;
Willett, Walter C. ;
Curhan, Gary C. .
HYPERTENSION, 2007, 49 (05) :1063-1069
[10]   The role of vitamin D in cancer prevention [J].
Garland, CF ;
Garland, FC ;
Gorham, ED ;
Lipkin, M ;
Newmark, H ;
Mohr, SB ;
Holick, MF .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2006, 96 (02) :252-261